Study Types


Since our inception in 1993, Baim has operationalized hundreds of clinical trials for registration. The services performed on these trials varied, from event adjudication through full trial execution. Additionally, we have worked with the FDA, defending study designs and speaking at panel meetings, creating a mutual familiarity between Baim and FDA. This experience provides sponsors with the confidence that Baim recognizes the requirements of clinical trial for registration and can be the partner that helps get their products to market.


As a not-for-profit academic research organization (ARO), a component of The Baim Institute’s mission is to perform clinical research that is purely academic in nature. Consequently, The Baim participates in many government-funded studies whose goal is not registration of new products, but rather the advancement of knowledge within the scientific and medical communities.


Compared to a clinical trial, registry studies offer a lower-cost option to learn about particular patient populations and trends. The Baim Institute has worked with many medical association and industry registries over the years and is currently Data Analytic Center (DAC) for the American College of Cardiology’s National Cardiovascular Data Registry (NCDR) Patient INNovation And CLinical Excellence (PINNACLE) Registry. Leading HCRI’s efforts in registry data analysis is Christopher Cannon, MD, Executive Director of Cardiometabolic Trials at Baim. Dr. Cannon’s experience includes leading more than 20 international randomized clinical trials over the past 20 years, working collaboratively with others on Executive Steering Committees.

Investigator-Initiated Studies

The Baim Institute provides an environment where scientific curiosity and investigation can be fostered. As our Faculty members are all active researchers, they are constantly generating new ideas or questions to be answered which lead to concept development for new clinical trials. These ideas are pitched to industry representatives in hopes of securing funding for the trials. Baim will act as the sponsor and fully operationalize the trial.


Outcomes research strives to analyze the effects of a treatment on a patient’s life, thereby providing guidance to clinicians and other healthcare practitioners in making decisions regarding patient care. The Baim Institute has participated in a wide range of Outcomes studies, some of which are federally-funded projects while others are for registration. We apply the same scientific and operational rigor to Outcomes studies that we do for all research activities, with the ultimate goal of improving the health and quality of life of the population.